ArticleJournal of colloid and interface science2021
Superhydrophobicity preventing surface contamination as a novel strategy against COVID-19.
Article in Journal of colloid and interface science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Antiviral Surface Protection of Polyhedral Oligomeric Silsesquioxanes (POSS)-Appended Hybrid Surface Materials.International journal of biomaterials · 2026Article
- Droplet Impact-Based Microliter Viscometry.Analytical chemistry · 2025Article
- SnOACS applied bio materials · 2025Article
- Tackling COVID-19 Using Antiviral Nanocoating's-Recent Progress and Future Challenges.Particle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems · 2023Review
- Role of bioaerosol in virus transmission and material-based countermeasures.Exploration (Beijing, China) · 2022Review
- Passive antifouling and active self-disinfecting antiviral surfaces.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2022Review
- A hand-targeted auxiliary personal protective equipment for intervention of fomite transmission of viruses.Bioengineering & translational medicine · 2022Article
- Asymmetric Jetting during the Impact of Liquid Drops on Superhydrophobic Concave Surfaces.Micromachines · 2022Article
- Constructing Superhydrophobic Surface on Copper Substrate with Dealloying-Forming and Solution-Immersion Method.Materials (Basel, Switzerland) · 2022Article
- Nanocoatings: Universal antiviral surface solution against COVID-19.Progress in organic coatings · 2022Review
- Recent Advances in Multifunctional Mechanical-Chemical Superhydrophobic Materials.Frontiers in bioengineering and biotechnology · 2022Review
- Liquid repellency enabled antipathogen coatings.Materials today. Bio · 2021Article
- Antimicrobial surfaces: a review of synthetic approaches, applicability and outlook.Journal of materials science · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface contact with virus is ubiquitous in the transmission pathways of respiratory diseases such as Coronavirus Disease 2019 (COVID-19), by which contaminated surfaces are infectious fomites intensifying the transmission of the disease. To date, the influence of surface wettability on fomite formation remains elusive. Here, we report that superhydrophobicity prevents the attachment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on surfaces by repelling virus-laden droplets. Compared to bare surfaces, superhydrophobic (SHPB) surfaces exhibit a significant reduction in SARS-CoV-2 attachment of up to 99.99995%. We identify the vital importance of solid-liquid adhesion in dominating viral attachment, where the viral activity (N) is proportional to the cube of solid-liquid adhesion (A), N ∝ A
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.